ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...
From his time in the industry before the contemporary good manufacturing practice (cGMP), senior drug substance consultant at DSI, a ProductLife Group company, Dave Adams quickly grasped the necessity ...
This upcoming webinar from Pharmaron Beijing Co., Ltd. examines the current market demand and trends for the late-phase manufacture and supply of small molecule drug substances. A range of speakers ...
Industry groups have identified upfront costs as a barrier to streamlining U.S. drugmaking. The nonprofit API Innovation Center has a proposed answer for how to tilt finances in favor of investments ...
Artificial intelligence is becoming a cornerstone for businesses seeking efficiency and scalability, from automating internal processes to enhancing customer-facing services. The GPT-5.2 API offers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results